Multiple reports were posted online yesterday stating that Anderson Silva’s recent victory over Nick Diaz, at UFC 183 in Las Vegas, had been overturned and ruled a no-contest.
These reports, which have surfaced due Silva’s failed drug tests leading up to the event, and Diaz’s after the event, have proven to be false.
Bob Bennett, the Executive Director of the Nevada Athletic Commission, spoke to MMA Weekly yesterday to clarify.
The result has not been adjusted yet, according to Bennett. Silva has 20 days from the time he was noticed of the failed tests to respond, and until then is under temporary suspension.
Silva failed random, out-of-competition testing conducted on January 9. The longtime middleweight champion, making his comeback after more than a year away from the sport due to injury, tested positive for drostanolone and androsterone. The former is an anabolic steroid, the latter a form of synthetic testosterone.
Diaz, a former welterweight title contender who was making his first UFC appearance at middleweight, failed his post-fight drug testing by scoring double the allowed amount of marijuana metabolites.
Silva is not required to respond in time for the next NAC meeting, which is February 17 — so nothing further may be known of his fate until March.